Decorin-Mediated Effects in Cancer Cell Biology

REFERENCES

• Danielson K. G., Baribault H., Holmes D. F., Graham H., Kadler K. E., Iozzo R. V. Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. J. Cell Biol. 1997; 136: 729–743
   PubMed Web of Science ®Google Scholar
• Iozzo R. V. The family of the small leucine-rich proteoglycans: key regulators of matrix assembly and cellular growth. Crit. Rev. Biochem. Mol. Biol. 1997; 32: 141–174
   PubMed Web of Science ®Google Scholar
• Vogel K. G., Paulsson M., Heinegard D. Specific inhibition of type I and type II collagen fibrillogenesis by the small proteoglycan of tendon. Biochem. J. 1984; 223: 587–597
   PubMed Web of Science ®Google Scholar
• Merle B., Durussel L., Delmas P. D., Clezardin P. Decorin inhibits cell migration through a process requiring its glycosaminoglycan side chain. J. Cell Biochem. 1999; 75: 538–546
   PubMed Web of Science ®Google Scholar
• Iozzo R.V., Cohen I. Altered proteoglycan gene expression and the tumor stroma. Experientia 1993; 49: 447–455
   PubMedGoogle Scholar
• McDoniels-Silvers A. L., Nimri C. F., Stoner G. D., Lubet R. A., You M. Differential gene expression in human lung adenocarcinomas and squamous cell carcinomas. Clin. Cancer Res. 2002; 8: 1127–1138
   PubMed Web of Science ®Google Scholar
• Shridhar V., Lee J., Pandita A., Iturria S., Avula R., Staub J., Morrissey M., Calhoun E., Sen A., Kalli K., Keeney G., Roche P., Cliby W., Lu K., Schmandt R., Mills G.B., Bast R.C. Jr., James C.D., Couch F.J., Hartmann L.C., Lillie J., Smith D.I. Genetic analysis of early-versus late-stage ovarian tumors. Cancer Res. 2001; 61: 5895–5904
   PubMed Web of Science ®Google Scholar
• Troup S., Njue C., Kliewer E. V., Parisien M., Roskelley C., Chakravarti S., Roughley P. J., Murphy L. C., Watson P. H. Reduced expression of the small leucine-rich proteoglycans, lumican, and decorin is associated with poor outcome in node-negative invasive breast cancer. Clin. Cancer Res. 2003; 9: 207–214
   PubMed Web of Science ®Google Scholar
• Santra M., Mann D. M., Mercer E. W., Skorski T., Calabretta B., Iozzo R. V. Ectopic expression of decorin protein core causes a generalized growth suppression in neoplastic cells of various histogenetic origin and requires endogenous p21, an inhibitor of cyclin-dependent kinases. J. Clin. Invest. 1997; 100: 149–157
   PubMed Web of Science ®Google Scholar
• Santra M., Skorski T., Calabretta B., Lattime E. C., Iozzo R. V. De novo decorin gene expression suppresses the malignant phenotype in human colon cancer cells. Proc. Natl. Acad. Sci. USA 1995; 92: 7016–7020
   PubMed Web of Science ®Google Scholar
• Schonherr E., Levkau B., Schaefer L., Kresse H., Walsh K. Decorin-mediated signal transduction in endothelial cells. Involvement of Akt/protein kinase B in up-regulation of p21(WAF1/CIP1) but not p27(KIP1). J. Biol. Chem. 2001; 276: 40687–40692
   PubMed Web of Science ®Google Scholar
• Xaus J., Comalada M., Cardo M., Valledor A. F., Celada A. Decorin inhibits macrophage colony-stimulating factor proliferation of macrophages and enhances cell survival through induction of p27(Kip1) and p21(Waf1). Blood 2001; 98: 2124–2133
   PubMed Web of Science ®Google Scholar
• Iozzo R. V., Moscatello D. K., McQuillan D. J., Eichstetter I. Decorin is a biological ligand for the epidermal growth factor receptor. J. Biol. Chem. 1999; 274: 4489–92
   PubMed Web of Science ®Google Scholar
• Moscatello D. K., Santra M., Mann D. M., McQuillan D. J., Wong A. J., Iozzo R. V. Decorin suppresses tumor cell growth by activating the epidermal growth factor receptor. J. Clin. Invest. 1998; 101: 406–412
   PubMed Web of Science ®Google Scholar
• Santra M., Reed C. C., Iozzo R. V. Decorin binds to a narrow region of the epidermal growth factor (EGF) receptor, partially overlapping but distinct from the EGF-binding epitope. J. Biol. Chem. 2002; 277: 35671–35681
   PubMed Web of Science ®Google Scholar
• Santra M., Eichstetter I., Iozzo R. V. An anti-oncogenic role for decorin. Down-regulation of ErbB2 leads to growth suppression and cytodifferentiation of mammary carcinoma cells. J. Biol. Chem. 2000; 275: 35153–35161
   PubMed Web of Science ®Google Scholar
• De Luca A., Santra M., Baldi A., Giordano A., Iozzo R. V. Decorin-induced growth suppression is associated with up-regulation of p21, an inhibitor of cyclin-dependent kinases. J. Biol. Chem. 1996; 271: 18961–18965
   PubMed Web of Science ®Google Scholar
• Nash M. A., Loercher A. E., Freedman R. S. in vitro growth inhibition of ovarian cancer cells by decorin: synergism of action between decorin and carboplatin. Cancer Res. 1999; 59: 6192–6196
   PubMed Web of Science ®Google Scholar
• Seidler D. G., Goldoni S., Agnew C., Cardi C., Thakur M. L., Owens R. T., McQuillan D. J., Iozzo R. V. Decorin protein core inhibits in vivo cancer growth and metabolism by hindering epidermal growth factor receptor function and triggering apoptosis via caspase-3 activation. J. Biol. Chem. 2006; 281: 26408–26418
   PubMed Web of Science ®Google Scholar
• Iozzo R. V., Chakrani F., Perrotti D., McQuillan D. J., Skorski T., Calabretta B., Eichstetter I. Cooperative action of germ-line mutations in decorin and p53 accelerates lymphoma tumorigenesis. Proc. Natl. Acad. Sci. USA 1999; 96: 3092–3097
   PubMed Web of Science ®Google Scholar
• Biglari A., Bataille D., Naumann U., Weller M., Zirger J., Castro M. G., Lowenstein P. R. Effects of ectopic decorin in modulating intracranial glioma progression in vivo, in a rat syngeneic model. Cancer Gene Ther. 2004; 11: 721–732
   PubMed Web of Science ®Google Scholar
• Reed C. C., Gauldie J., Iozzo R. V. Suppression of tumorigenicity by adenovirus-mediated gene transfer of decorin. Oncogene 2002; 21: 3688–3695
   Web of Science ®Google Scholar
• Tralhao J. G., Schaefer L., Micegova M., Evaristo C., Schonherr E., Kayal S., Veiga-Fernandes H., Danel C., Iozzo R. V., Kresse H., Lemarchand P. In vivo selective and distant killing of cancer cells using adenovirus-mediated decorin gene transfer. FASEB J. 2003; 17: 464–466
   PubMed Web of Science ®Google Scholar
• Reed C. C., Waterhouse A., Kirby S., Kay P., Owens R. T., McQuillan D. J., Iozzo R. V. Decorin prevents metastatic spreading of breast cancer. Oncogene 2005; 24: 1104–1110
   PubMed Web of Science ®Google Scholar
• Benayahu D., Shur I., Marom R., Meller I., Issakov J. Cellular and molecular properties associated with osteosarcoma cells. J. Cell Biochem. 2001; 84: 108–114
   PubMed Web of Science ®Google Scholar
• Zafiropoulos A., Nikitoric D., Katonis P., Tsatsakis A., Karamanos N. K., Tzanakakis G. N. Decorin-induced growth inhibition is overcome through protracted expression and activation of epidermal growth facter receptors in osteosarcoma cells. Mol. Cancer Res. 2008; 6: 785–794
   PubMed Web of Science ®Google Scholar
• Bodo M., Lilli C., Bellucci C., Carinci P., Calvitti M., Pezzetti F., Stabellini G., Bellocchio S., Balducci C., Carinci F., Baroni T. Basic fibroblast growth factor autocrine loop controls human osteosarcoma phenotyping and differentiation. Mol. Med. 2002; 8: 393–404
   PubMed Web of Science ®Google Scholar
• Franchi A., Arganini L., Baroni G., Calzolari A., Capanna R., Campanacci D., Caldora P., Masi L., Brandi M. L., Zampi G. Expression of transforming growth factor beta isoforms in osteosarcoma variants: association of TGF beta 1 with high-grade osteosarcomas. J. Pathol. 1998; 185: 284–289
   PubMed Web of Science ®Google Scholar
• Liang Y., Robinson D. F., Dennig J., Suske G., Fahl W. E. Transcriptional regulation of the SIS/PDGF-B gene in human osteosarcoma cells by the Sp family of transcription factors. J. Biol. Chem. 1996; 271: 11792–11797
   PubMed Web of Science ®Google Scholar
• Sulzbacher I., Traxler M., Mosberger I., Lang S., Chott A. Platelet-derived growth factor-AA and -alpha receptor expression suggests an autocrine and/or paracrine loop in osteosarcoma. Mod. Pathol. 2000; 13: 632–637
   PubMed Web of Science ®Google Scholar
• Nili N., Cheema A. N., Giordano F. J., Barolet A. W., Babaei S., Hickey R., Eskandarian M. R., Smeets M., Butany J., Pasterkamp G., Strauss B. H. Decorin inhibition of PDGF-stimulated vascular smooth muscle cell function: potential mechanism for inhibition of intimal hyperplasia after balloon angioplasty. Am. J. Pathol. 2003; 163: 869–878
   PubMed Web of Science ®Google Scholar
• Yamaguchi Y., Mann D. M., Ruoslahti E. Negative regulation of transforming growth factor-beta by the proteoglycan decorin. Nature 1990; 346: 281–284
   PubMed Web of Science ®Google Scholar
• Csordas G., Santra M., Reed C. C., Eichstetter I., McQuillan D. J., Gross D., Nugent M. A., Hajnoczky G., Iozzo R. V. Sustained down-regulation of the epidermal growth factor receptor by decorin. A mechanism for controlling tumor growth in vivo. J. Biol. Chem. 2000; 275: 32879–32887
   PubMed Web of Science ®Google Scholar
• Normanno N., De Luca A., Bianco C., Strizzi L., Mancino M., Maiello M. R., Carotenuto A., De Feo G., Caponigro F., Salomon D. S. Epidermal growth factor receptor (EGFR) signaling in cancer. Gene 2006; 366: 2–16
   PubMed Web of Science ®Google Scholar
• Torrisi M. R., Lotti L. V., Belleudi F., Gradini R., Salcini A. E., Confalonieri S., Pelicci P. G., Di Fiore P. P. Eps15 is recruited to the plasma membrane upon epidermal growth factor receptor activation and localizes to components of the endocytic pathway during receptor internalization. Mol. Biol. Cell 1999; 10: 417–434
   PubMed Web of Science ®Google Scholar
• Levkowitz G., Waterman H., Zamir E., Kam Z., Oved S., Langdon W. Y., Beguinot L., Geiger B., Yarden Y. c-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor. Genes Dev. 1998; 12: 3663–3674
   PubMed Web of Science ®Google Scholar
• Zhu J. X., Goldoni S., Bix G., Owens R. T., McQuillan D. J., Reed C. C., Iozzo R. V. Decorin evokes protracted internalization and degradation of the epidermal growth factor receptor via caveolar endocytosis. J. Biol. Chem. 2005; 280: 32468–32479
   PubMed Web of Science ®Google Scholar